Wook Kim
Director of Finance/CFO at HLB GLOBAL CO., LTD.
Wook Kim active positions
| Companies | Position | Start | End |
|---|---|---|---|
| HLB CO., LTD. | Director/Board Member | - | - |
| HLB GLOBAL CO., LTD. | Director/Board Member | 31/07/2018 | - |
| Director of Finance/CFO | 31/07/2018 | - |
Career history of Wook Kim
Former positions of Wook Kim
| Companies | Position | Start | End |
|---|---|---|---|
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Director/Board Member | 31/12/2018 | - |
Training of Wook Kim
| Korea University | Undergraduate Degree |
Statistics
International
| South Korea | 4 |
| United States | 2 |
Operational
| Director/Board Member | 3 |
| Director of Finance/CFO | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Energy Minerals | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| HLB CO., LTD. | Health Technology |
| HLB GLOBAL CO., LTD. | Energy Minerals |
| Private companies | 1 |
|---|---|
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
- Stock Market
- Insiders
- Wook Kim
- Experience
